Comment from The Geneva Foundation, HHS-OPHS-2018-0021, HHS-OPHS-2018-0021-0001, N/A
The Geneva FoundationOtherIndividual
Summary: The commenter submitted a clinical trial informed consent form for a study on GS-9674 for Primary Sclerosing Cholangitis. The submission does not express a position on the proposed action regarding the posting of consent forms on federal websites.
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Non-Cirrhotic Subjects with Primary Sclerosing Cholangitis- BAMC